Psychedelics California startup Tactogen gets U.S. patent for MDMA derivatives The company focuses on developing novel psychoactive drugs with more gentle effects Rowan DunneSeptember 27, 2023
Canada Filament and Jaguar’s joint venture Magdalena imports Peruvian coca leaves to Vancouver The leaves were obtained from the Empresa Nacional de la Coca (ENACO) -- Peru's only authorized distributor Rowan DunneSeptember 22, 2023
Psychedelics Billionaire Steve Cohen’s Point 72 hedge fund takes 8.1% stake in Cybin It now has 19 million shares of the psychedelic drug developer, the firm's first investment in a public entity of this variety Rowan DunneSeptember 19, 2023
Psychedelics Sweden’s Norrsken Foundation launches $4.4M psychedelics mental health initiative Funds will be used to study psilocybin and MDMA-assisted therapy; non-profit says Sweden needs to 'catch up' in this area of research Rowan DunneSeptember 14, 2023
News Silo Pharma to test a novel experimental intranasal formulation for PTSD Silo's SPC-15 was developed in collaboration with Columbia University Natalia Buendia CalvilloSeptember 13, 2023
News Lucy Scientific acquires BlueSky Wellness portfolio of brands Lucy expects to complete the acquisition within 90 days Natalia Buendia CalvilloSeptember 12, 2023
Psychedelics AI shows potential for predicting psilocybin therapy outcomes: COMPASS study The paper in the journal Psychopharmacology concluded that a machine learning algorithm could predict treatment efficacy Rowan DunneSeptember 8, 2023
Cannabis Lucy Scientific Discovery acquires High Times IP, expects $10M of revenue growth in 2024 Lucy also expects to add $5 million of EBITDA to its financial results next year from the deal Rowan DunneSeptember 8, 2023
News Clearmind to collaborate with Johns Hopkins University to study promising psychedelic treatment for alcohol use disorder Johns Hopkins University School of Medicine is the second U.S. clinical site to join Clearmind's trial, following Yale School of Medicine's psychiatry department Natalia Buendia CalvilloSeptember 6, 2023
Psychedelics PharmAla Biotech lists on the OTCQB middle-tier venture market The MDMA producer is now trading under the symbol PMBHF, which is intended to attract more investors in the U.S. Rowan DunneSeptember 6, 2023